Holen Sie sich die Stockscreener-App
2.875
0.88%
0.025
Vorhandelsmarkt:
3.00
0.125
+4.35%
Schlusskurs vom Vortag:
$2.85
Offen:
$2.85
24-Stunden-Volumen:
269.46K
Relative Volume:
1.33
Marktkapitalisierung:
$92.72M
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-1.4532
EPS:
-1.9784
Netto-Cashflow:
-
1W Leistung:
-2.38%
1M Leistung:
-57.22%
6M Leistung:
+0.00%
1J Leistung:
+0.00%
1-Tages-Spanne:
$2.64
$2.9105
1-Wochen-Bereich:
$2.34
$3.2299
52-Wochen-Spanne:
$2.34
$8.79
Anteris Technologies Global Corp Stock (AVR) Company Profile
Firmenname
Anteris Technologies Global Corp
Sektor
Telefon
651-493-0606
Adresse
860 BLUE GENTIAN ROAD, EAGAN
Vergleichen Sie AVR mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
AVR
Anteris Technologies Global Corp
|
2.875 | 92.72M | 0 | 0 | 0 | -1.9784 |
|
ISRG
Intuitive Surgical Inc
|
482.74 | 175.60B | 8.35B | 2.32B | 1.30B | 6.41 |
|
BDX
Becton Dickinson Co
|
198.71 | 59.07B | 20.64B | 1.73B | 2.94B | 6.02 |
|
ALC
Alcon Inc
|
92.54 | 44.80B | 9.91B | 1.02B | 665.00M | 2.05 |
|
RMD
Resmed Inc
|
212.91 | 31.51B | 4.93B | 1.25B | 1.38B | 8.47 |
|
COO
The Cooper Companies, Inc.
|
79.51 | 15.75B | 3.90B | 392.30M | 288.10M | 1.95 |
Anteris Technologies Global Corp Stock (AVR) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-01-08 | Eingeleitet | Lake Street | Buy |
| 2025-01-07 | Eingeleitet | Barclays | Overweight |
| 2025-01-07 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2025-01-07 | Eingeleitet | TD Cowen | Buy |
Anteris Technologies Global Corp Aktie (AVR) Neueste Nachrichten
Cantor Fitzgerald maintains Anteris stock Overweight with $9 target By Investing.com - Investing.com India
Anteris Technologies Announces New Securities Quotation - TipRanks
Anteris Technologies Announces Cessation of Securities - TipRanks
NanoVibronix (NASDAQ:NAOV) & Anteris Technologies Global (NASDAQ:AVR) Head to Head Review - Defense World
Anteris Technologies Reports March 2025 CDI Adjustments - TipRanks
Anteris Technologies Marks Clinical Milestone with DurAVR® THV By Investing.com - Investing.com Canada
Anteris reports over 100 patients treated with new heart valve By Investing.com - Investing.com South Africa
Anteris Technologies Hits Milestone with DurAVR® Heart Valve Treatment - Zenopa
Anteris Technologies Reaches Clinical Milestone: 100 patients treated with DurAVR® THV - GlobeNewswire
Anteris reports over 100 patients treated with new heart valve - Investing.com
Anteris Technologies announces 100 patients treated with DurAVR THV - TipRanks
Anteris Technologies Achieves Key Milestone in Cardiac Care - TipRanks
Anteris Technologies Marks Clinical Milestone with DurAVR® THV - Investing.com
Anteris Technologies Achieves Milestone with DurAVR® Heart Valve - TipRanks
Anteris Technologies marks clinical milestone with more than 100 patients treated using flagship DurAVR® THV - Proactive financial news
ASX Health Stocks: Anteris plans for US IPO and listing on Nasdaq - MSN
Head to Head Survey: Anteris Technologies Global (NASDAQ:AVR) & United Health Products (OTCMKTS:UEEC) - Defense World
Anteris Technologies reports one-year patient outcomes for DurAVR THV - TipRanks
Anteris shares rise on positive valve trial results By Investing.com - Investing.com Canada
Anteris Reports One-Year Patient Outcomes for DurAVR® THV - The Manila Times
Anteris shares rise on positive valve trial results - Investing.com India
Anteris Technologies Unveils Positive DurAVR® Patient Outcomes - TipRanks
Anteris Technologies delivers strong one-year results for DurAVR® Transcatheter Heart Valve - Proactive financial news
Analyzing Anteris Technologies Global (NASDAQ:AVR) & CollPlant Biotechnologies (NASDAQ:CLGN) - Defense World
Anteris Technologies Global (NASDAQ:AVR) Stock Price Down 6.2% – What’s Next? - Defense World
Anteris Technologies: Advancing Toward FDA Approval with Positive Buy Rating - TipRanks
Anteris Technologies reports annual financial results By Investing.com - Investing.com South Africa
Anteris Technologies reports annual financial results - Investing.com India
Anteris Reports 2024 Financial Results and Provides Corporate Update - The Manila Times
Anteris Technologies: A Trailblazing Year of Innovation and Expansion - Kondor EXP
The morning catch up: ASX to reverse losses despite war of words over tariffs - Proactive financial news
Anteris Technologies: A Transformational Leap with Its Nasdaq Debut and Heart Valve Breakthroughs - Kondor EXP
Anteris Technologies 2024 financials strong following Nasdaq debut, with plans for heart valve pivotal trial this year - Proactive Investors USA
Proactive financial news: fast, accessible, and actionable articles and videos for the global investment audience. - Proactive Investors Australia
Anteris Technologies Reports 2024 Financial Results and Advances Heart Valve Innovations - TipRanks
Anteris Technologies Reports Increased Losses Amid Strategic Reorganization - TipRanks
Anteris Technologies Global Corp. (AVR) reports earnings - Quartz
Small cap wrap: Ocean Power Technologies, Zero Candida, Liberty Star Minerals... - Proactive Investors UK
Anteris Technologies Issues New Shares to Bolster Financial Position - TipRanks
Anteris Technologies appoints David St Denis as President and Class II director - Proactive financial news
Anteris Technologies Appoints New President to Strengthen Leadership - TipRanks
Finanzdaten der Anteris Technologies Global Corp-Aktie (AVR)
Umsatz
Nettogewinn
Free Cashflow
ENV
Anteris Technologies Global Corp-Aktie (AVR) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Paterson Wayne | Chief Executive Officer |
Mar 05 '25 |
Option Exercise |
7.13 |
233,000 |
1,661,290 |
233,000 |
| Denaro Stephen | Director |
Mar 11 '25 |
Option Exercise |
7.13 |
16,500 |
117,645 |
23,722 |
0.90%
3.46%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):